Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Ritter

Showing results (101-110 of 119) with videos related to

Pageof 12
Sort By:
Tissue Engineering. Part C, Methods|February 7, 2009
Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cellsBrian Kealy, Aaron Liew, Jill M McMahon, et al.
The Ocular Surface|February 6, 2025
Development and optimization of an ex vivo model of corneal epithelium damage with 1-heptanol: Investigating the influence of donor clinical parameters and MSC-sEV treatment on healing capacityFilippo Bonelli, Seyedmohammad Moosavizadeh, Elisa Fasolo, et al.
Tissue Engineering. Part A|April 12, 2008
Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrateGemma E Rooney, Cathal Moran, Siobhan S McMahon, et al.
Transplantation|November 26, 2019
High-risk Corneal Transplantation: Recent Developments and Future PossibilitiesW John Armitage, Christine Goodchild, Matthew D Griffin, et al.
Tissue Engineering. Part A|April 2, 2009
Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cellsGemma E Rooney, Siobhan S McMahon, Thomas Ritter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2020
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In VivoKevin Lynch, Oliver Treacy, Xizhe Chen, et al.
Cancer Research|January 20, 2004
Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapyPer S Holm, Hermann Lage, Stephan Bergmann, et al.
Oncoimmunology|February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosisSerika D Naicker, Claire L Feerick, Kevin Lynch, et al.
The Journal of Experimental Medicine|January 22, 2004
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitisNaoto Kawakami, Silke Lassmann, Zhaoxia Li, et al.
Iscience|September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signalingNiamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Pageof 12

Showing results (101-110 of 119) with videos related to

Sort By:
Pageof 12
Tissue Engineering. Part C, Methods|February 7, 2009
Comparison of viral and nonviral vectors for gene transfer to human endothelial progenitor cellsBrian Kealy, Aaron Liew, Jill M McMahon, et al.
The Ocular Surface|February 6, 2025
Development and optimization of an ex vivo model of corneal epithelium damage with 1-heptanol: Investigating the influence of donor clinical parameters and MSC-sEV treatment on healing capacityFilippo Bonelli, Seyedmohammad Moosavizadeh, Elisa Fasolo, et al.
Tissue Engineering. Part A|April 12, 2008
Gene-modified mesenchymal stem cells express functionally active nerve growth factor on an engineered poly lactic glycolic acid (PLGA) substrateGemma E Rooney, Cathal Moran, Siobhan S McMahon, et al.
Transplantation|November 26, 2019
High-risk Corneal Transplantation: Recent Developments and Future PossibilitiesW John Armitage, Christine Goodchild, Matthew D Griffin, et al.
Tissue Engineering. Part A|April 2, 2009
Neurotrophic factor-expressing mesenchymal stem cells survive transplantation into the contused spinal cord without differentiating into neural cellsGemma E Rooney, Siobhan S McMahon, Thomas Ritter, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2020
TGF-β1-Licensed Murine MSCs Show Superior Therapeutic Efficacy in Modulating Corneal Allograft Immune Rejection In VivoKevin Lynch, Oliver Treacy, Xizhe Chen, et al.
Cancer Research|January 20, 2004
Multidrug-resistant cancer cells facilitate E1-independent adenoviral replication: impact for cancer gene therapyPer S Holm, Hermann Lage, Stephan Bergmann, et al.
Oncoimmunology|February 8, 2021
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosisSerika D Naicker, Claire L Feerick, Kevin Lynch, et al.
The Journal of Experimental Medicine|January 22, 2004
The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitisNaoto Kawakami, Silke Lassmann, Zhaoxia Li, et al.
Iscience|September 23, 2024
Tumor-associated mesenchymal stromal cells modulate macrophage phagocytosis in stromal-rich colorectal cancer via PD-1 signalingNiamh A Leonard, Shania M Corry, Eileen Reidy, et al.
Pageof 12